Fed Circ finds another CardioNet patent-ineligible under Alice
02-11-2021
Fed Circuit backs Endo in Alice suit over oxymorphone patent
29-03-2019
MiniStocker / Shutterstock.com
There has been a significant drop in the number of patents invalidated due to so-called Alice challenges since Federal Circuit rulings in Berkheimer v HP, and Aatrix Software v Green Shades Software, according to a new report.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
patent validity, Alice, RPX, patent risk management, patent eligibility, patent infringement, Berkheimer, Aatrix, Cellspin
